Venetoclax for treating refractory autoimmune hemolytic anemia in chronic lymphocytic leukemia: report of two cases in Spain

被引：1
作者：
Galindo-Navarro, Pablo [1 ]
Delgado-Garcia, Alicia [1 ]
Rodriguez-Gil, Miguel A. [1 ]
Puerta-Puerta, Jose M. [1 ]
机构：
[1] Hosp Univ Virgen De La Nieves, Unidad Gest Clin Hematol & Hemoterapia, Granada, Spain
来源：
HAEMATOLOGICA | 2023年 / 108卷 / 08期
关键词：
CYTOPENIAS; CLL;
D O I：
10.3324/haematol.2022.281850
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2261 / 2264
页数：4
相关论文
共 36 条
  • [21] Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naive and Relapsed or Refractory Chronic Lymphocytic Leukemia
    Rogers, Kerry A.
    Huang, Ying
    Ruppert, Amy S.
    Abruzzo, Lynne V.
    Andersen, Barbara L.
    Awan, Farrukh T.
    Bhat, Seema A.
    Dean, Allison
    Lucas, Margaret
    Banks, Christin
    Grantier, Cara
    Heerema, Nyla A.
    Lozanski, Gerard
    Maddocks, Kami J.
    Valentine, Thomas R.
    Weiss, David M.
    Jones, Jeffrey A.
    Woyach, Jennifer A.
    Byrd, John C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (31) : 3626 - +
  • [22] Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia
    Flinn, Ian W.
    Gribben, John G.
    Dyer, Martin J. S.
    Wierda, William
    Maris, Michael B.
    Furman, Richard R.
    Hillmen, Peter
    Rogers, Kerry A.
    Iyer, Swaminathan Padmanabhan
    Quillet-Mary, Anne
    Ysebaert, Loic
    Walter, Harriet S.
    Verdugo, Maria
    Klein, Christian
    Huang, Huang
    Jiang, Yanwen
    Lozanski, Gerard
    Pignataro, Daniela Soriano
    Humphrey, Kathryn
    Mobasher, Mehrdad
    Kipps, Thomas J.
    BLOOD, 2019, 133 (26) : 2765 - 2775
  • [23] Efficacy of venetoclax and rituximab in the treatment of concurrent acute myeloid leukemia and untreated chronic lymphocytic leukemia: A case report and literature review
    Chen, Yafang
    Yuan, Linyu
    Lu, Xinxiao
    Wang, Xue
    Zhang, Qiuqiu
    Wang, Xiaofang
    Zhao, Xingli
    ONCOLOGY LETTERS, 2024, 28 (02)
  • [24] Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
    Izutsu, Koji
    Yamamoto, Kazuhito
    Kato, Koji
    Ishikawa, Takayuki
    Fukuhara, Noriko
    Terui, Yasuhito
    Choi, Ilseung
    Humphrey, Kathryn
    Kim, Su Young
    Okubo, Sumiko
    Ogawa, Natsumi
    Nishimura, Yasuko
    Salem, Ahmed Hamed
    Maruyama, Dai
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 370 - 380
  • [25] Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)
    Quinquenel, Anne
    Willekens, Christophe
    Dupuis, Jehan
    Royer, Bruno
    Ysebaert, Loic
    De Guibert, S.
    Michallet, Anne-Sophie
    Feugier, Pierre
    Guieze, Romain
    Levy, Vincent
    Delmer, Alain
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (03) : 204 - 207
  • [26] Toward personalized therapy for chronic lymphocytic leukemia DSC and cDNA microarray assessment of two cases
    Rogalinska, Malgorzata
    Franiak-Pietryga, Ida
    Blonski, Jerzy Z.
    Goralski, Pawel
    Maciejewski, Henryk
    Janus, Agnieszka
    Robak, Pawel
    Mirowski, Marek
    Piekarski, Henryk
    Robak, Tadeusz
    Kilianska, Zofia M.
    CANCER BIOLOGY & THERAPY, 2013, 14 (01) : 6 - 12
  • [27] Venetoclax alone or in combination with other regimens treatment achieve deep and sustained remission of relapsed/refractory chronic lymphocytic leukemia: a meta-analysis
    Tang, Xiao
    Zou, Wenrong
    Peng, Peng
    Bai, Yanglu
    CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 22 (02) : 161 - 171
  • [28] Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax
    Kotmayer, Lili
    Laszlo, Tamas
    Mikala, Gabor
    Kiss, Richard
    Levay, Luca
    Hegyi, Lajos Laszlo
    Grof, Stefania
    Nagy, Tibor
    Barna, Gabor
    Farkas, Peter
    Weisinger, Julia
    Nagy, Zsolt
    Balogh, Alexandra
    Masszi, Tamas
    Demeter, Judit
    Sulak, Adrienn
    Kohl, Zoltan
    Alizadeh, Hussain
    Egyed, Miklos
    Pettendi, Piroska
    Gergely, Lajos
    Plander, Mark
    Pauker, Zsolt
    Masszi, Andras
    Matolcsy, Andras
    Szasz, Robert
    Bodor, Csaba
    Alpar, Donat
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [29] Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia
    Huntington, Scott F.
    Manzoor, Beenish S.
    Puckett, Justin T.
    Kamal-Bahl, Sachin
    Alhasani, Hasan
    Ravelo, Arliene
    Jawaid, Dureshahwar
    Doshi, Jalpa A.
    LEUKEMIA & LYMPHOMA, 2023, 64 (14) : 2316 - 2323
  • [30] t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: Report of two cases and a literature review
    Chen, Weifeng
    Miao, Yi
    Wang, Rong
    Wu, Yujie
    Qiu, Hairong
    Xu, Wei
    Li, Jianyong
    Fan, Lei
    Xu, Xin
    ONCOLOGY LETTERS, 2016, 12 (06) : 4351 - 4356
1234